Evaluation of DNA/Ligand Interactions by Electrospray Ionization Mass Spectrometry

被引:41
作者
Brodbelt, Jennifer S. [1 ]
机构
[1] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA
来源
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 3 | 2010年 / 3卷
关键词
tandem mass spectrometry; noncovalent complexes; DNA/drug complex; binding affinity; binding selectivity; DOUBLE-STRANDED OLIGODEOXYNUCLEOTIDES; DNA-BINDING DRUGS; CYTOTOXIC PROTOBERBERINE ALKALOIDS; GAS-PHASE STABILITY; G-QUADRUPLEX DNA; NONCOVALENT COMPLEXES; DUPLEX DNA; ESI-MS; OLIGONUCLEOTIDE DUPLEX; LIGAND-BINDING;
D O I
10.1146/annurev.anchem.111808.073627
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrospray ionization mass spectrometry (ESI-MS) has enabled the detection and characterization of DNA/ligand complexes, including evaluation of both relative binding affinities and selectivities of DNA-interactive ligands. The noncovalent complexes that are transferred from the solution to the gas phase retain the signature of the native species, thus allowing the use of MS to screen DNA/ligand complexes, reveal the stoichiometries of the complexes, and provide insight into the nature of the interactions. Ligands that bind to DNA via metal-mediated modes and those that bind to unusual DNA structures, such as quadruplexes, are amenable to EST. Chemical probe methods applied to DNA/ligand complexes with ESI-MS detection afford information about ligand-binding sites and conformational changes of DNA that occur upon ligand binding.
引用
收藏
页码:67 / 87
页数:21
相关论文
共 65 条
[1]   Selective recognition of pyrimidine-pyrimidine DNA mismatches by distance-constrained macrocyclic bis-intercalators [J].
Bahr, Matthias ;
Gabelica, Valerie ;
Granzhan, Anton ;
Teulade-Fichou, Marie-Paule ;
Weinhold, Elmar .
NUCLEIC ACIDS RESEARCH, 2008, 36 (15) :5000-5012
[2]   Recent developments in mass spectrometry for the characterization of nucleosides, nucleotides, oligonucleotides, and nucleic acids [J].
Banoub, JH ;
Newton, RP ;
Esmans, E ;
Ewing, DF ;
Mackenzie, G .
CHEMICAL REVIEWS, 2005, 105 (05) :1869-1915
[3]   Probing DNA selectivity of ruthenium metallointercalators using ESI mass spectrometry [J].
Beck, JL ;
Gupta, R ;
Urathamakul, T ;
Williamson, NL ;
Sheil, MM ;
Aldrich-Wright, JR ;
Ralph, SF .
CHEMICAL COMMUNICATIONS, 2003, (05) :626-627
[4]   Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins [J].
Beck, JL ;
Colgrave, ML ;
Ralph, SF ;
Sheil, MM .
MASS SPECTROMETRY REVIEWS, 2001, 20 (02) :61-87
[5]   DNA-binding of drugs used in medicinal therapies [J].
Bischoff, G ;
Hoffmann, S .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (03) :321-348
[6]   Intercalators as anticancer drugs [J].
Braña, MF ;
Cacho, M ;
Gradillas, A ;
de Pascual-Teresa, B ;
Ramos, A .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) :1745-1780
[7]  
Bui Chinh T., 2004, Current Pharmacogenomics, V2, P325, DOI 10.2174/1570160043377312
[8]   Permanganate oxidation reactions of DNA: Perspective in biological studies [J].
Bui, CT ;
Rees, K ;
Cotton, RGH .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (09) :1835-1855
[9]  
Carrasco C, 2002, CHEMBIOCHEM, V3, P1235, DOI 10.1002/1439-7633(20021202)3:12<1235::AID-CBIC1235>3.0.CO
[10]  
2-I